Cognitive decline among persons 65 years or older (hereinafter seniors) is a pressing health care issue. Effective pharmacologic treatment of mild cognitive impairment and dementia remains a major medical challenge.
1 Hence, effective primary prevention strategies for cognitive decline would greatly benefit individuals and society.